What is congenital myasthenic syndrome 13? Definition, Meaning & Symptoms — Medical Dictionary
← Medical Dictionary
📂 Diseases

congenital myasthenic syndrome 13 — Definition

Konjenital miyastenik sendrom 13 / congenital myasthenic syndrome 13
Congenital miyastenic syndrome is a rare disease that occurs as a result of a genetic mutation that affects the structure or function of proteins contained in the nerve-cassing cavity (e.g. evenmuse). This condition is characterized by weakness of muscles, weakness of weakness, which is aggravated by weakness, fatigue and especially repetitive movements. Symptoms often start from birth or early childhood, and may contain findings such as pitosis (eye cover miscarriage), ophthalmoparezi ( weakness in the eye muscles) and respiratory strength. The severity and speed of progression of the disease vary depending on the affected genetic mutation.
Turkish
🇹🇷 Konjenital miyastenik sendrom 13
English
🇬🇧 congenital myasthenic syndrome 13
Category
📂 Diseases
Medical Dictionary
🏥 Medical Dictionary

Disease Definition

🔬 Disease Definition
Konjenital miyastenik sendrom tip 13, nöromüsküler kavşakta presinaptik vezikül döngüsünde bozukluğa yol açan SLC18A3 gen mutasyonlarından kaynaklanan nadir bir genetik hastalıktır. Doğumdan itibaren veya erken çocuklukta kas güçsüzlüğü ve yorgunluk ile karakterizedir.
🧬 Causes & Risk Factors
SLC18A3 genindeki otozomal resesif mutasyonlar, asetilkolin taşıyıcısını etkileyerek nöromüsküler kavşakta sinyal iletimini bozar. Aile öyküsü ve akraba evliliği risk faktörleridir.
🩺 Symptoms & Signs
Proksimal kas güçsüzlüğü, pitozis, oftalmoparezi, yutma güçlüğü, solunum sıkıntısı ve egzersizle artan yorgunluk. Semptomlar genellikle doğumda veya bebeklikte başlar.
📋 Diagnostic Methods
Klinik değerlendirme, elektromiyografi (tekrarlayan sinir stimülasyonu ile azalma), asetilkolinesteraz inhibitörlerine yanıt ve genetik test (SLC18A3 mutasyon analizi) ile konur.
💊 Treatment Options
Asetilkolinesteraz inhibitörleri (piridostigmin) ve 3,4-diaminopiridin semptomatik tedavide kullanılır. Solunum desteği ve fizik tedavi gerekebilir. Bazı hastalar immünsüpresif tedaviye yanıt vermez.
⚠️ Complications
Solunum yetmezliği, aspirasyon pnömonisi, beslenme güçlüğü ve kalıcı kas atrofisi. Şiddetli vakalarda yaşamı tehdit eden solunum krizleri.

Frequently Asked Questions

❓ What is Konjenital miyastenik sendrom 13?
Konjenital miyastenik sendrom 13; congenital miyastenic syndrome is a rare disease that occurs as a result of a genetic mutation that affects the structure or function of proteins contained in the nerve-cassing cavity (e.g. evenmuse). This condition is characterized by weakness of muscles, weakness of weakness, which is aggravated by weakness, fatigue and especially repetitive movements. Symptoms often start from birth or early childhood, and may contain findings such as pitosis (eye cover miscarriage), ophthalmoparezi ( weakness in the eye muscles) and respiratory strength. The severity and speed of progression of the disease vary depending on the affected genetic mutation.
❓ What is congenital myasthenic syndrome 13 in Turkish?
The Turkish equivalent of "congenital myasthenic syndrome 13" is Konjenital miyastenik sendrom 13.
❓ Which medical field is Konjenital miyastenik sendrom 13 related to?
This term belongs to the Diseases category.